Quality and compliance as a strategic capability
Turning regulatory pressure into operational strength
Quality & compliance is no longer just QA’s responsibility. It has become a strategic capability that drives speed to market, supply reliability, inspection readiness, and patient trust across the life sciences industry.
At the same time, life sciences companies are navigating an increasingly complex regulatory and operational landscape. Today, many life sciences organizations are facing at least three major pressure waves simultaneously.
The three pressure waves facing life sciences
Sterility assurance
Contamination Control Strategy (CCS) per EudraLex Annex 1 is no longer accepted to be “just a document”. It is increasingly expected to function as a real, facility-wide, holistic operating system that connects people, processes, equipment, utilities, and continuous improvement.1
Digital validation & data integrity
Digitalization continues to accelerate across manufacturing and quality environments. But compliance expectations have not disappeared, they have rather expanded. The recent release of the GAMP Good Practice Guide reflects that shift, with added attention to cloud and SaaS integration, modular plants, OT cybersecurity, and AI in process control contexts.
So, the question is no longer just Do we have validation documents? It is: Do we have an operating model that keep our systems in a validated state while the business changes? And the business is changing fast.
MDR/IVDR readiness, now with AI governance added
For MedTech companies, the pressure is still very real: notified body capacity, technical documentation quality, PMS maturity, and EUDAMED readiness.
The European Commission has confirmed that the first four EUDAMED modules become mandatory from 28 May 2026, adding another concrete milestone for manufacturers to prepare for.2
At the same time, AI is adding a new governance layer. The MDCG 2025-6 FAQ on the interplay between MDR/IVDR and the AI Act makes clear that this is a complementary, dual-compliance landscape rather than a replacement of one framework with another. 3
The common theme in these? The organizations handling these topics best are rarely the ones simply working harder. They are the ones working earlier, more cross-functionally, being science & data driven and planning more systematically.
Addressing key challenges in quality and compliance
In practice, the biggest needs often show up in:
- gap assessments and remediation roadmaps
- CCS implementation and operationalization
- CQV and lifecycle validation
- CSV/CSA and data integrity by design
- targeted GxP and regulatory capability building
Where are you seeing the most friction right now within your business: sterility assurance, digital validation, MDR/IVDR readiness, AI governance, or somewhere else? You are not alone.
Where AFRY typically supports our customers is when the waves of changes and expectations hit simultaneously and companies need integrated capability across engineering, QA, and delivery.
Typical AFRY offerings
- Gap-assessment
- Training and education of personnel
- QRM-led quality planning and project governance
- Project planning and execution
- Commissioning, qualification, and validation (CQV)
- Contamination control strategy (CCS) implementation
- CSV/CSA and data integrity by design
Gap-assessments of existing systems and practices at our customers, establishing roadmaps to continuous improvements and increased quality and compliance
Training and education of personnel are key to building robust quality and compliance capabilities. This includes customized sessions tailored to areas such as quality/compliance (GxP), regulatory requirements, qualification and validation, and project management.
AFRY provides quality planning and project governance driven by Quality Risk Management (QRM). This includes risk-based scope definition, milestone planning, and structured decision-making to ensure effective and efficient project execution.
AFRY offers a wide range of competencies and skills in project management, automation, plant design, quality assurance, and validation. Support is available across all project phases, from early feasibility studies to filing for regulatory approval of new facilities.
AFRY delivers CQV services with strong supplier leverage and a lifecycle approach. These services can be executed within AFRY’s own QMS systems, using established procedures and templates, or within any customer document management system.
AFRY supports CCS implementation through a structured approach, starting with gap assessments, followed by roadmap development, and operationalization within the overall pharmaceutical quality management system.
AFRY ensures computer system validation (CSV) and computer software assurance (CSA) are integrated with data integrity principles. This includes designing systems across MES, LIMS, and PCS with interface mapping and robust records governance.
Quality and compliance are no longer standalone support functions. They are essential business capabilities that directly influence operational performance, regulatory readiness, and patient trust.
Organizations that work proactively, cross-functionally, and strategically will be better equipped to manage increasing complexity and future regulatory expectations.
AFRY supports life sciences companies with integrated expertise across engineering, quality, validation, and compliance to help turn these challenges into long-term capability. Are you ready to tackle your quality and compliance challenges? Let’s start the conversation today.
Engineering the future of life science manufacturing
Explore how AFRY helps organizations achieve these goals through integrated engineering, quality, digitalization, and project delivery services across the entire facility lifecycle.
Footnotes
- 1. https://www.pda.org/pda-letter-portal/home/full-article/eu-gmp-annex-1.-implementation-of-contamination-control-strategy a↩
- 2. https://health.ec.europa.eu/latest-updates/eudamed-four-first-modules-will-be-mandatory-use-28-may-2026-2025-11-27_en a↩
- 3. https://health.ec.europa.eu/document/download/b78a17d7-e3cd-4943-851d-e02a2f22bbb4_en?filename=mdcg_2025-6_en.pdf a↩